Prior history of the macaques enrolled in the present study
Macaque . | Prior treatment . | Absolute CD4 count/mm3 . | SIV RNA copies/mL . |
|---|---|---|---|
| Group 1 | |||
| 208L | ALVAC | 1014 | 1 512 120 |
| 887L* | ALVAC-SIV | 603 | 525 050 |
| 897L* | CD4-IgG2 and DNA-ALVAC-SIV | 622 | 1 742 940 |
| 205M* | CD4-IgG2 and DNA-ALVAC-SIV | 705 | 3 500 550 |
| 912 | ALVAC-SIV‡ | 1167 | 5 868 690 |
| 262M | ALVAC‡ | 357 | 50 300 |
| 894L* | ALVAC-SIV§ | 1510 | 1 000 |
| 895L* | ALVAC-SIV§ | 357 | 441 110 |
| 930L | ALVAC-SIV§ | 612 | 1 654 420 |
| Group 2† | |||
| 886L* | DNA-ALVAC-SIV | 943 | 253 130 |
| 234M | ALVAC‡ | 704 | 137 538 |
| 284M | ALVAC§ | 943 | 1 382 140 |
| 891L* | ALVAC-SIV‡ | 274 | 1 000 |
| 892L* | ALVAC-SIV‡ | 143 | 56 222 |
| 910 | ALVAC-SIV‡ | 472 | 42 322 |
| 917 | ALVAC-SIV§ | 697 | 3 860 570 |
| 931L | ALVAC-SIV§ | 995 | 3 652 680 |
Macaque . | Prior treatment . | Absolute CD4 count/mm3 . | SIV RNA copies/mL . |
|---|---|---|---|
| Group 1 | |||
| 208L | ALVAC | 1014 | 1 512 120 |
| 887L* | ALVAC-SIV | 603 | 525 050 |
| 897L* | CD4-IgG2 and DNA-ALVAC-SIV | 622 | 1 742 940 |
| 205M* | CD4-IgG2 and DNA-ALVAC-SIV | 705 | 3 500 550 |
| 912 | ALVAC-SIV‡ | 1167 | 5 868 690 |
| 262M | ALVAC‡ | 357 | 50 300 |
| 894L* | ALVAC-SIV§ | 1510 | 1 000 |
| 895L* | ALVAC-SIV§ | 357 | 441 110 |
| 930L | ALVAC-SIV§ | 612 | 1 654 420 |
| Group 2† | |||
| 886L* | DNA-ALVAC-SIV | 943 | 253 130 |
| 234M | ALVAC‡ | 704 | 137 538 |
| 284M | ALVAC§ | 943 | 1 382 140 |
| 891L* | ALVAC-SIV‡ | 274 | 1 000 |
| 892L* | ALVAC-SIV‡ | 143 | 56 222 |
| 910 | ALVAC-SIV‡ | 472 | 42 322 |
| 917 | ALVAC-SIV§ | 697 | 3 860 570 |
| 931L | ALVAC-SIV§ | 995 | 3 652 680 |